Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Caris Life Sciences, Inc.CAI · Entity 3706 | Director | August 14, 2026 | August 14, 2026 |
| GLAUKOS CorpGKOS · Entity 3510 | PRESIDENT & COO | August 11, 2026 | August 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Caris Life Sciences, Inc.
Report date August 14, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,321 |
Reported balance
After 2026-08-14 transaction · row 1
1 source rowRow 1 · 2026-08-14 · Grant · Acquired 13,192 · Balance 29,321 F1: Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.
GLAUKOS Corp
Report date August 11, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 72,588 |
Last balance in matching sequence
After 2026-08-11 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rowsRow 1 · 2026-08-11 · Exercise / conversion · Acquired 10,000 · Balance 82,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 2 · 2026-08-11 · Exercise / conversion · Acquired 20,000 · Balance 102,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 3 · 2026-08-11 · Exercise / conversion · Acquired 20,000 · Balance 122,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 4 · 2026-08-11 · Exercise / conversion · Acquired 10,000 · Balance 132,588 F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 5 · 2026-08-11 · Sale · Disposed 27,963 · Balance 104,625 F2: This transaction was executed in multiple trades at prices ranging from $178.60 to $179.58). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Row 6 · 2026-08-11 · Sale · Disposed 32,037 · Balance 72,588 F3: This transaction was executed in multiple trades at prices ranging from $179.68 to $180.60). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.18 · Expires 2032-03-24 | Direct | 51,475 |
Reported balance
After 2026-08-11 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-11 · Exercise / conversion · Disposed 20,000 · Balance 51,475 F4: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.18 · Expires 2032-03-24 | Direct | 33,118 |
Reported balance
After 2026-08-11 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-11 · Exercise / conversion · Disposed 20,000 · Balance 33,118 F5: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. F6: Total amount reported has been adjusted to correct a typographical error made in a Form 4 report filed by the Reporting Person on March 17, 2025, in which 13,721 stock options earned were erroneously reported as 13,271 stock options. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.46 · Expires 2033-03-22 | Direct | 26,751 |
Reported balance
After 2026-08-11 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-08-11 · Exercise / conversion · Disposed 10,000 · Balance 26,751 F7: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.46 · Expires 2033-03-22 | Direct | 26,751 |
Reported balance
After 2026-08-11 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-08-11 · Exercise / conversion · Disposed 10,000 · Balance 26,751 F8: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F2: This transaction was executed in multiple trades at prices ranging from $178.60 to $179.58). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $179.68 to $180.60). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
F5: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals.
F6: Total amount reported has been adjusted to correct a typographical error made in a Form 4 report filed by the Reporting Person on March 17, 2025, in which 13,721 stock options earned were erroneously reported as 13,271 stock options.
F7: These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
F8: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2024 Filed Apr 5, 2024 22:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 200 | $96.61 | $19,322.00 |
DisclosureSEC source: 0001415889-24-010452 · form4-04052024_100443.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,845 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 22:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 200 | $55.18 | $11,036.00 |
DisclosureSEC source: 0001415889-24-010452 · form4-04052024_100443.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 00:26 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 13,721 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-010196 · form4-04042024_120408.xml · derivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,442 Underlying: Common Stock · 13,721 shares Expires 2032-03-24 F3 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation, Nominating & Governance Committee determined on April 1, 2024 the level of achievement for the second year of the multi-year performance period. The number of shares of common stock subject to the stock option reported herein consists of the portion of the shares subject to the stock option that vested with respect to 100% of the second-year performance goal. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 00:26 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 1,964 | $93.10 | $182,848.40 |
DisclosureSEC source: 0001415889-24-010196 · form4-04042024_120408.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,845 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 18, 2021. F2 · balance_after: Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 20:49 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 4,593 | $88.72 | $407,490.96 |
DisclosureSEC source: 0001415889-24-009549 · form4-04012024_080405.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,809 F3 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 24, 2022. F4 · balance_after: Includes 80,294 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 20:49 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 2,615 | $88.08 | $230,329.20 |
DisclosureSEC source: 0001415889-24-009549 · form4-04012024_080405.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,402 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 22, 2023. F2 · balance_after: Includes 89,355 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 15,161 | $0.00 Strike: $85.78 | $0.00 |
DisclosureSEC source: 0001415889-24-008358 · form4-03182024_110359.xml · derivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,161 Underlying: Common Stock · 15,161 shares Expires 2034-03-14 F7 · derivative.exercise_date: This option was granted on March 14, 2024 and has a four-year vesting schedule in which 25% vests on the first anniversary of the grant date and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 3,660 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-008358 · form4-03182024_110359.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,596 Underlying: Common Stock · 3,660 shares Expires 2032-03-24 F5 · shares: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on March 14, 2024 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. F6 · derivative.exercise_date: 50% of the portion of the option reported herein will vest and become exercisable in March 2024, and the remaining 50% will vest and become exercisable in December 2024. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 8,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008358 · form4-03182024_110359.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,017 F3 · shares: Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date. F4 · balance_after: Includes 94,514 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 23:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 3,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008358 · form4-03182024_110359.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,274 F1 · shares: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 18, 2021, the earning and vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 14, 2024 that one of the operational targets had been achieved. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement of the operational target. 50% of the number of shares of common stock reported herein will vest and be delivered in March 2024 and the remaining 50% will vest and be delivered in December 2024. F2 · balance_after: Includes 85,771 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| March 14, 2024 Filed Mar 27, 2024 20:41 UTC Amendment | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 15,353 | $0.00 Strike: $85.78 | $0.00 |
DisclosureSEC source: 0001415889-24-009213 · form4a-03272024_080328.xml · derivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,353 Underlying: Common Stock · 15,353 shares Expires 2034-03-14 F1 · shares: This Form 4A amends a Form 4 filed March 18, 2024 that incorrectly reported the number of options granted to the Reporting Person on March 14, 2024 as 15,161. The correct number of options granted was 15,353, as shown above. F2 · derivative.exercise_date: This option was granted on March 14, 2024 and has a four-year vesting schedule in which 25% vests on the first anniversary of the grant date and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 02:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,607 | $0.00 Strike: $39.10 | $0.00 |
DisclosureSEC source: 0001415889-24-005638 · form4-02282024_020223.xml · derivative · entry 11 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,607 shares Expires 2030-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 12, 2020, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. F11 · balance_after: The amount reported reflects an adjustment of 5,000 shares underlying a stock option grant reported as exercised on a Form 4 filed with the Securities and Exchange Commission on February 12, 2024. The exercise was inadvertently attributed to the stock option grant issued on 3/12/2020 and subject to a time-based vesting schedule, but should have been attributed to the stock option grant issued on 3/12/2020 and subject to performance-based vesting requirements. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 02:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 26,671 | $0.00 Strike: $39.10 | $0.00 |
DisclosureSEC source: 0001415889-24-005638 · form4-02282024_020223.xml · derivative · entry 10 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,053 Underlying: Common Stock · 26,671 shares Expires 2030-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option was granted on March 12, 2020 and has a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. F9 · balance_after: The amount reported reflects an adjustment of 5,000 shares underlying a stock option grant reported as exercised on a Form 4 filed with the Securities and Exchange Commission on February 12, 2024. The exercise was inadvertently attributed to the stock option grant issued on 3/12/2020 and subject to a time-based vesting schedule, but should have been attributed to the stock option grant issued on 3/12/2020 and subject to performance-based vesting requirements. In addition, the amount reported takes into account a reconciliation adjustment to reflect the Reporting Person's economic interest in the shares underlying this stock option grant to comply with the terms of a domestic relations order issued in connection with a marital dissolution. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 02:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,128 | $0.00 Strike: $30.92 | $0.00 |
DisclosureSEC source: 0001415889-24-005638 · form4-02282024_020223.xml · derivative · entry 9 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,128 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option was granted on March 14, 2018 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. F6 · balance_after: The amount reported takes into account a reconciliation adjustment to reflect the Reporting Person's economic interest in the shares underlying this stock option grant to comply with the terms of a domestic relations order issued in connection with a marital dissolution. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 02:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 74,425 | $0.00 Strike: $41.69 | $0.00 |
DisclosureSEC source: 0001415889-24-005638 · form4-02282024_020223.xml · derivative · entry 8 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,929 Underlying: Common Stock · 74,425 shares Expires 2027-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. F6 · balance_after: The amount reported takes into account a reconciliation adjustment to reflect the Reporting Person's economic interest in the shares underlying this stock option grant to comply with the terms of a domestic relations order issued in connection with a marital dissolution. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 02:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 4,092 | $93.05 | $380,760.60 |
DisclosureSEC source: 0001415889-24-005638 · form4-02282024_020223.xml · nonDerivative · entry 7 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,388 F4 · price: This transaction was executed in multiple trades at prices ranging from $92.80 to $93.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 02:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 114,739 | $92.33 | $10,593,851.87 |
DisclosureSEC source: 0001415889-24-005638 · form4-02282024_020223.xml · nonDerivative · entry 6 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,480 F3 · price: This transaction was executed in multiple trades at prices ranging from $91.79 to $92.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 02:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 21,414 | $90.94 | $1,947,389.16 |
DisclosureSEC source: 0001415889-24-005638 · form4-02282024_020223.xml · nonDerivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,219 F2 · price: This transaction was executed in multiple trades at prices ranging from $90.37 to $91.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 02:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 4,607 | $39.10 | $180,133.70 |
DisclosureSEC source: 0001415889-24-005638 · form4-02282024_020223.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 02:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 13,128 | $30.92 | $405,917.76 |
DisclosureSEC source: 0001415889-24-005638 · form4-02282024_020223.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 234,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 02:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 74,425 | $41.69 | $3,102,778.25 |
DisclosureSEC source: 0001415889-24-005638 · form4-02282024_020223.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 02:29 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 26,671 | $39.10 | $1,042,836.10 |
DisclosureSEC source: 0001415889-24-005638 · form4-02282024_020223.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:56 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,512 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-003767 · form4-02142024_090237.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,936 Underlying: Common Stock · 1,512 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F5 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:56 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 1,512 | $96.80 | $146,361.60 |
DisclosureSEC source: 0001415889-24-003767 · form4-02142024_090237.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,802 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $96.57 to $97.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:56 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 1,512 | $55.18 | $83,432.16 |
DisclosureSEC source: 0001415889-24-003767 · form4-02142024_090237.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 23:41 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 631 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-24-003420 · form4-02122024_110218.xml · derivative · entry 6 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,448 Underlying: Common Stock · 631 shares Expires 2032-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F7 · derivative.exercise_date: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 23:41 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 631 | $96.70 | $61,017.70 |
DisclosureSEC source: 0001415889-24-003420 · form4-02122024_110218.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,802 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $96.57 to $97.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 23:41 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 631 | $55.18 | $34,818.58 |
DisclosureSEC source: 0001415889-24-003420 · form4-02122024_110218.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,433 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:41 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $39.10 | $0.00 |
DisclosureSEC source: 0001415889-24-003420 · form4-02122024_110218.xml · derivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,466 Underlying: Common Stock · 5,000 shares Expires 2030-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F6 · derivative.exercise_date: This option was granted on March 12, 2020 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:41 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 5,000 | $96.07 | $480,350.00 |
DisclosureSEC source: 0001415889-24-003420 · form4-02122024_110218.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,802 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $96.01 to $96.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 23:41 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 5,000 | $39.10 | $195,500.00 |
DisclosureSEC source: 0001415889-24-003420 · form4-02122024_110218.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,476 | $0.00 Strike: $39.10 | $0.00 |
DisclosureSEC source: 0001415889-24-002083 · form4-01312024_100118.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,466 Underlying: Common Stock · 9,476 shares Expires 2030-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F5 · derivative.exercise_date: This option was granted on March 12, 2020 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 9,476 | $94.12 | $891,881.12 |
DisclosureSEC source: 0001415889-24-002083 · form4-01312024_100118.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,802 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $94.01 to $94.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:35 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 9,476 | $39.10 | $370,511.60 |
DisclosureSEC source: 0001415889-24-002083 · form4-01312024_100118.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:04 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 524 | $0.00 Strike: $39.10 | $0.00 |
DisclosureSEC source: 0001415889-24-001779 · form4-01242024_110137.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,942 Underlying: Common Stock · 524 shares Expires 2030-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F4 · derivative.exercise_date: This option was granted on March 12, 2020 and has a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:04 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 524 | $94.01 | $49,261.24 |
DisclosureSEC source: 0001415889-24-001779 · form4-01242024_110137.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,802 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:04 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 524 | $39.10 | $20,488.40 |
DisclosureSEC source: 0001415889-24-001779 · form4-01242024_110137.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 22:30 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,890 | $0.00 Strike: $30.92 | $0.00 |
DisclosureSEC source: 0001415889-24-001532 · form4-01182024_050101.xml · derivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,437 Underlying: Common Stock · 4,890 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F5 · derivative.exercise_date: This option was granted on March 14, 2018 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 22:30 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 4,890 | $89.17 | $436,041.30 |
DisclosureSEC source: 0001415889-24-001532 · form4-01182024_050101.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,802 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $89.01 to $89.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 22:30 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 4,890 | $30.92 | $151,198.80 |
DisclosureSEC source: 0001415889-24-001532 · form4-01182024_050101.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 21:59 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 110 | $0.00 Strike: $30.92 | $0.00 |
DisclosureSEC source: 0001415889-24-001111 · form4-01162024_090125.xml · derivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,327 Underlying: Common Stock · 110 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F6 · derivative.exercise_date: This option was granted on March 14, 2018 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 21:59 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 110 | $89.01 | $9,791.10 |
DisclosureSEC source: 0001415889-24-001111 · form4-01162024_090125.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,802 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F2 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 21:59 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 110 | $30.92 | $3,401.20 |
DisclosureSEC source: 0001415889-24-001111 · form4-01162024_090125.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 21:59 UTC | GLAUKOS Corp GKOS · Entity 3510 | Tax withholdingCommon Stock | 199 | $77.08 | $15,338.92 |
DisclosureSEC source: 0001415889-24-001111 · form4-01162024_090125.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,802 F1 · shares: Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer. F2 · balance_after: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| December 21, 2023 Filed Dec 22, 2023 23:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $41.69 | $0.00 |
DisclosureSEC source: 0001415889-23-016914 · form4-12222023_111232.xml · derivative · entry 5 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,044 Underlying: Common Stock · 25,000 shares Expires 2027-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F8 · derivative.exercise_date: This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Read SEC document |
| December 21, 2023 Filed Dec 22, 2023 23:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 3,200 | $85.58 | $273,856.00 |
DisclosureSEC source: 0001415889-23-016914 · form4-12222023_111232.xml · nonDerivative · entry 4 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,001 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $85.44 to $85.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Includes 82,275 restricted stock units that have not yet vested or not yet been delivered to the Reporting Person. Read SEC document |
| December 21, 2023 Filed Dec 22, 2023 23:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 16,965 | $84.97 | $1,441,516.05 |
DisclosureSEC source: 0001415889-23-016914 · form4-12222023_111232.xml · nonDerivative · entry 3 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,201 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F5 · price: This transaction was executed in multiple trades at prices ranging from $84.44 to $85.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Includes 82,275 restricted stock units that have not yet vested or not yet been delivered to the Reporting Person. Read SEC document |
| December 21, 2023 Filed Dec 22, 2023 23:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 4,835 | $83.70 | $404,689.50 |
DisclosureSEC source: 0001415889-23-016914 · form4-12222023_111232.xml · nonDerivative · entry 2 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,166 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $83.38 to $84.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Includes 82,275 restricted stock units that have not yet vested or not yet been delivered to the Reporting Person. Read SEC document |
| December 21, 2023 Filed Dec 22, 2023 23:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 25,000 | $41.69 | $1,042,250.00 |
DisclosureSEC source: 0001415889-23-016914 · form4-12222023_111232.xml · nonDerivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 82,275 restricted stock units that have not yet vested or not yet been delivered to the Reporting Person. Also reflects a prior transfer by the Reporting Person of 88 shares of common stock pursuant a domestic relations order in connection with a marital dissolution. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 23:59 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 3,659 | $0.00 Strike: $55.18 | $0.00 |
DisclosureSEC source: 0001415889-23-016331 · form4-12122023_111241.xml · derivative · entry 1 Gilliam Joseph E · CIK 0001705850 · PRESIDENT & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,079 Underlying: Common Stock · 3,659 shares Expires 2032-03-24 F1 · shares: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee determined on December 8, 2023 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. F2 · derivative.exercise_date: 50% of the portion of the option reported herein will vest and become exercisable in February 2024, and the remaining 50% will vest and become exercisable in November 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.